about
Mutations in the gene encoding 3 beta-hydroxysteroid-delta 8, delta 7-isomerase cause X-linked dominant Conradi-Hünermann syndromeMolecular cloning and expression of the human delta7-sterol reductasePhenylalkylamine Ca2+ antagonist binding protein. Molecular cloning, tissue distribution, and heterologous expressionThe mysteries of sigma receptors: new family members reveal a role in cholesterol synthesis7-Dehydrocholesterol-dependent proteolysis of HMG-CoA reductase suppresses sterol biosynthesis in a mouse model of Smith-Lemli-Opitz/RSH syndromeProspective virtual screening in a sparse data scenario: design of small-molecule TLR2 antagonists.Purified skeletal muscle 1,4-dihydropyridine receptor forms phosphorylation-dependent oligomeric calcium channels in planar bilayers.Torpor: The Rise and Fall of 3-Monoiodothyronamine from Brain to Gut-From Gut to Brain?Genetic defects in postsqualene cholesterol biosynthesis.Novel pharmacological chaperones that correct phenylketonuria in mice.Does rosuvastatin increase serum levels of 25-hydroxy-vitamin D?A marriage of two "Methusalem" drugs for the treatment of psoriasis?: Arguments for a pilot trial with metformin as add-on for methotrexate.Calcium channels from Cyprinus carpio skeletal muscle.Identification of 1,4-dihydropyridine binding regions within the alpha 1 subunit of skeletal muscle Ca2+ channels by photoaffinity labeling with diazipineVitamin D, UV, and skin cancer in the elderly: to expose or not to expose?Coordination of Ca2+ by the pore region glutamates is essential for high-affinity dihydropyridine binding to the cardiac Ca2+ channel alpha 1 subunit.Identification of PK-A phosphorylation sites in the carboxyl terminus of L-type calcium channel alpha 1 subunits.Pharmacology and structure of high conductance calcium-activated potassium channels.Images in cardiovascular medicine. Generalized large vessel arteritis visualized by 18fluorodeoxyglucose-positron emission tomography.Conserved Ca2+-antagonist-binding properties and putative folding structure of a recombinant high-affinity dihydropyridine-binding domain.Differential effects of Ca2+ channel beta1a and beta2a subunits on complex formation with alpha1S and on current expression in tsA201 cells.Reversible labeling of a chemosensitizer binding domain of p-glycoprotein with a novel 1,4-dihydropyridine drug transport inhibitor.Benzothiazepine binding domain of purified L-type calcium channels: direct labeling using a novel fluorescent diltiazem analogue.Improved micro-perfusion chamber for multiple and rapid solution exchange in adherent single cells.Calcium channels: the beta-subunit increases the affinity of dihydropyridine and Ca2+ binding sites of the alpha 1-subunit.Visualization of the domain structure of an L-type Ca2+ channel using electron cryo-microscopy.A novel 1,4-dihydropyridine-binding site on mitochondrial membranes from guinea-pig heart, liver and kidney.Very high affinity interaction of DPI 201-106 and BDF 8784 enantiomers with the phenylalkylamine-sensitive Ca2(+)-channel in Drosophila head membranes.Oral supplementation with calcitriol, calcidiol, vitamin D3 or moderate sun exposure?Mechanism of dihydropyridine interaction with critical binding residues of L-type Ca2+ channel alpha 1 subunits.Association of the src-gene product of Rous sarcoma virus with a pyruvate-kinase inactivation factor.Hydrophobic calcium channel ligands: methodical problems and their solution.The increase in hormone-stimulated adenylate cyclase activity following Rous sarcoma virus transformation.Inhibition of cardiac L-type calcium channels by quaternary amlodipine: implications for pharmacokinetics and access to dihydropyridine binding site.Photoaffinity labelling of the phenylalkylamine receptor of the skeletal muscle transverse-tubule calcium channel.Photoaffinity labelling of Ca2+ channels with [3H]azidopine.Target size analysis and molecular properties of Ca2+ channels labelled with [3H]verapamil.Molecular structure of rat brain apamin receptor: differential photoaffinity labeling of putative K+ channel subunits and target size analysis.Putative calcium channel molecular weight determination by target size analysis.Target size analysis of skeletal muscle Ca2+ channels. Positive allosteric heterotropic regulation by d-cis-diltiazem is associated with apparent channel oligomer dissociation.
P50
Q22010196-BA5B65E9-DC40-4B94-AC32-E4DA93461789Q24310118-5E036979-448E-425B-B200-451584A85294Q24313077-316FF9B5-D0F2-4957-9724-C39B3442C27CQ28236929-A9780C23-C8FB-4588-9AD7-DCE56855C636Q28354262-129E1AAB-8E34-4F0F-BA95-97DA72290CD8Q30743434-10498A00-2512-47E5-81BA-A61B84EEDC0CQ33581091-0490D3E9-2B30-4652-84B9-914B5E1A0C5EQ33742405-2965E08E-A020-4C41-8A79-B75ACB614C8BQ33856618-47A9C9ED-F707-4072-B0F5-A3BD21D3F26FQ34127906-25C0E22F-4284-48BC-B545-3269EC4EF7F9Q36130004-B7176E0E-C506-4B6A-B2DF-341184E95BE5Q37170305-547F68FB-0434-46E5-94CE-C7A6FD10CD54Q37383348-8F9935A8-B37A-43C9-A24F-6C79C082BB13Q37608461-142BF61E-1101-4B28-9500-A55F5BBE2138Q37825379-8A500600-B55D-4019-95AD-95D8AFD25864Q38293337-AE2A2F6C-330E-4038-98C9-F6AB8C9D0B5BQ38355117-89D44DB6-4C83-4058-AF71-A674531FB092Q40507546-EA2CFA2E-A308-4664-AD8C-2F8B8BAD32DBQ40565189-707F9A60-4E8E-4C12-ADCA-E4856F5A65C5Q40886220-C64B996F-3B19-4DCD-9724-0C3DA69CCF30Q41043670-D190476D-85BB-4B11-805D-36B32219F4F0Q41229327-0755FE01-BE67-49C4-B664-689F6CDA7BFCQ41360417-4366BABF-B99B-462B-9E4D-15CAF938FD65Q41403782-2BBF7EAB-C668-4E01-9841-0E812494E26DQ41441648-CA40EBC3-6780-4523-A2C8-EDA10E1368F0Q41629081-4F7C2B18-05B2-49A6-B346-8989CCB8A749Q42159967-6B7B9542-462C-4FB8-A29C-2D78E2D2EC6FQ42237253-63E789F4-770E-4084-A4BA-03778F889D18Q42438045-7AEDE3DD-9D09-4C3A-907E-BBA6723CFB43Q43559720-D2F4DF18-6F0B-4DED-95F6-86CBDDAEB3EFQ43612036-EDA96998-19C1-43DD-B8A5-2C5EA38D5E5CQ44413422-380FD1B1-31CD-4F16-8CD7-806372EDE22FQ45800159-7BC9E479-9E98-46C4-AAE9-765213BFDD53Q46435490-D4A1DF24-A233-4F1B-B16B-6E64972CFACCQ46461157-A4BE3E79-45E4-4BD5-A48F-6143EE104FBBQ46815234-7422DB90-3658-4B46-B632-F281F4284CF7Q46955294-7E035FCF-3BDC-40CC-9AC7-0EF89BD98490Q47206881-FAC9844F-4E24-4E62-8784-6D3FB01F43E1Q47251789-D9FF03A5-41AA-4172-A9C3-31D56080BFE5Q47252918-B343E401-BA5A-4965-9F46-A42C4E37986C
P50
description
Forscher
@de
chercheur
@fr
investigador
@es
researcher
@en
ricercatore
@it
wetenschapper
@nl
研究者
@zh
name
H Glossmann
@ast
H Glossmann
@en
H Glossmann
@es
H Glossmann
@nl
type
label
H Glossmann
@ast
H Glossmann
@en
H Glossmann
@es
H Glossmann
@nl
prefLabel
H Glossmann
@ast
H Glossmann
@en
H Glossmann
@es
H Glossmann
@nl
P31
P496
0000-0002-7392-3266